NDC11 71904020003
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71904-0200-03 | 71904-0200 |
| 71904-0200-3 | 71904-0200 |
| 71904-200-03 | 71904-200 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POMBILITI ATGA | CIPAGLUCOSIDASE ALFA-ATGA | AMICUS THERAPEUTICS US, LLC | d77aa596-910d-516b-e053-2995a90a0839 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 71904-200-03 71904-200 71904020003 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.